ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LGND Ligand Pharmaceuticals Incorporated

72.52
0.00 (0.00%)
Pre Market
Last Updated: 07:40:58
Delayed by 15 minutes

Period:

Draw Mode:

Volume 2
Bid Price 71.42
Ask Price 80.00
News -
Day High

Low
49.24

52 Week Range

High
94.57

Day Low
Company Name Stock Ticker Symbol Market Type
Ligand Pharmaceuticals Incorporated LGND NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 72.52 07:40:58
Open Price Low Price High Price Close Price Prev Close
72.52
Trades Volume Avg Volume 52 Week Range
2 2 - 49.24 - 94.57
Last Trade Time Type Quantity Stock Price Currency
08:00:06 1 $ 74.00 USD

Ligand Pharmaceuticals Incorporated Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.28B 17.71M - 131.31M 52.15M 2.95 24.62
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Ligand Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No LGND Message Board. Create One! See More Posts on LGND Message Board See More Message Board Posts

Historical LGND Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week81.4881.7372.5078.76162,116-8.96-11.00%
1 Month72.9181.7368.24576.71150,685-0.39-0.53%
3 Months75.5594.5768.24576.21173,871-3.03-4.01%
6 Months53.8094.5749.2470.67140,58818.7234.80%
1 Year75.6394.5749.2469.98119,585-3.11-4.11%
3 Years148.67169.9849.2495.70144,453-76.15-51.22%
5 Years126.00219.7549.24106.02240,677-53.48-42.44%

Ligand Pharmaceuticals Description

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Your Recent History

Delayed Upgrade Clock